Hanford Tank Waste Operations & Closure, LLC Approved to Begin Hanford Tanks Cleanup Contract
(LYNCHBURG, Va. – October 17, 2024) – BWX Technologies, Inc. (NYSE: BWXT) is pleased to announce that Hanford Tank Waste Operations & Closure, LLC (H2C) has been approved by the U.S. Department of Energy (DOE) to begin the Hanford Integrated Tank Disposition Contract (ITDC).
BWXT Names Gary D. Camper President of Nuclear Operations Group Subsidiary
(LYNCHBURG, Va. – Sept. 3, 2024) – BWX Technologies, Inc. (NYSE: BWXT) announced today that Gary D. Camper has been appointed president of BWXT Nuclear Operations Group, Inc. (NOG) effective Sept. 1, 2024.
BWXT Named First Member of GE Vernova Nuclear’s Small Modular Reactor Supplier Group
BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. has been selected as the first qualified supply chain company to join the GE Vernova nuclear business’ supplier group that will advance the global deployment of the BWRX-300 small modular reactor (SMR).
BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market
BWX Technologies, Inc. (NYSE: BWXT) announced an investment to expand its Cambridge manufacturing plant.
BWXT Canada Joins Canadians for CANDU® Campaign
BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), has joined the Canadians for CANDU Campaign.
UK Space Agency Awards Space Reactor Development Project to BWXT and Rolls-Royce
BWX Technologies, Inc. announced that it and Rolls-Royce have secured funding for Phase 2 of the UK Space Agency’s International Bilateral Fund (IBF).
BWXT Releases 2024 Sustainability Report
BWX Technologies, Inc. (NYSE: BWXT) has released its 2024 Sustainability Report.
BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site
BWX Technologies, Inc. announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington.
BWX Technologies Reports Fourth Quarter and Full Year 2023 Results, Initiates 2024 Guidance
BWX Technologies, Inc. (NYSE: BWXT) reported fourth quarter and full year 2023 results.
BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology
(OTTAWA, Ontario – November 16, 2023) – BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.